Lachey Jennifer
CIK 0001808322 Name as filed on the most recent filing
Filed as Lachey Jennifer (17)
47 transaction lines · from 17 filings · filed 2021-02-16 to 2022-07-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
47 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2022-07-15 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 46,034 disposed | 30.00 | 1,381,020.00 | Form 4, filing 0001209191-22-042573 | |
| 2022-07-13 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,916 disposed | 30.00 | 57,480.00 | Form 4, filing 0001209191-22-042253 | |
| 2022-05-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 3,398 disposed | 41.26 | 140,201.48 | Form 4, filing 0001209191-22-028889 | |
| 2022-05-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 944 disposed | 42.49 | 40,110.56 | Form 4, filing 0001209191-22-028889 | |
| 2022-05-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 719 disposed | 43.32 | 31,147.08 | Form 4, filing 0001209191-22-028889 | |
| 2022-05-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 223 disposed | 44.23 | 9,863.29 | Form 4, filing 0001209191-22-028889 | |
| 2022-05-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 16 disposed | 45.45 | 727.20 | Form 4, filing 0001209191-22-028889 | |
| 2022-04-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 2,315 disposed | 63.50 | 147,002.50 | Form 4, filing 0001209191-22-024290 | |
| 2022-04-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,417 disposed | 61.37 | 86,961.29 | Form 4, filing 0001209191-22-024290 | |
| 2022-04-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,009 disposed | 62.32 | 62,880.88 | Form 4, filing 0001209191-22-024290 | |
| 2022-04-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 559 disposed | 64.15 | 35,859.85 | Form 4, filing 0001209191-22-024290 | |
| 2022-04-04 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 7,950 disposed | 60.00 | 477,000.00 | Form 4, filing 0001209191-22-023494 | |
| 2022-03-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,062 disposed | 52.43 | 55,680.66 | Form 4, filing 0001209191-22-018836 | |
| 2022-03-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 875 disposed | 54.54 | 47,722.50 | Form 4, filing 0001209191-22-018836 | |
| 2022-03-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 713 disposed | 53.36 | 38,045.68 | Form 4, filing 0001209191-22-018836 | |
| 2022-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,378 disposed | 52.35 | 72,138.30 | Form 4, filing 0001209191-22-009792 | |
| 2022-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,073 disposed | 51.50 | 55,259.50 | Form 4, filing 0001209191-22-009792 | |
| 2022-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 199 disposed | 53.10 | 10,566.90 | Form 4, filing 0001209191-22-009792 | |
| 2022-01-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,196 disposed | 53.56 | 64,057.76 | Form 4, filing 0001209191-22-003198 | |
| 2022-01-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,134 disposed | 54.45 | 61,746.30 | Form 4, filing 0001209191-22-003198 | |
| 2022-01-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 320 disposed | 52.01 | 16,643.20 | Form 4, filing 0001209191-22-003198 | |
| 2022-01-05 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 2,650 disposed | 60.00 | 159,000.00 | Form 4, filing 0001209191-22-002416 | |
| 2021-12-15 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 735 disposed | 50.00 | 36,750.00 | Form 4, filing 0001209191-21-069767 | |
| 2021-12-13 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,518 disposed | 50.11 | 76,066.98 | Form 4, filing 0001209191-21-069767 | |
| 2021-12-13 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 390 disposed | 52.22 | 20,365.80 | Form 4, filing 0001209191-21-069767 | |
| 2021-12-13 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 7 disposed | 53.64 | 375.48 | Form 4, filing 0001209191-21-069767 | |
| 2021-11-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 4,561 disposed | 59.78 | 272,656.58 | Form 4, filing 0001209191-21-064218 | |
| 2021-11-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 739 disposed | 58.73 | 43,401.47 | Form 4, filing 0001209191-21-064218 | |
| 2021-11-10 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 15,900 disposed | 60.00 | 954,000.00 | Form 4, filing 0001209191-21-064218 | |
| 2021-11-04 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 10,600 disposed | 50.00 | 530,000.00 | Form 4, filing 0001209191-21-063210 | |
| 2021-06-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,533 disposed | 50.37 | 77,217.21 | Form 4, filing 0001209191-21-040651 | |
| 2021-06-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 898 disposed | 51.73 | 46,453.54 | Form 4, filing 0001209191-21-040651 | |
| 2021-06-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 219 disposed | 52.13 | 11,416.47 | Form 4, filing 0001209191-21-040651 | |
| 2021-05-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 2,650 disposed | 50.00 | 132,500.00 | Form 4, filing 0001209191-21-032358 | |
| 2021-04-12 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 3,473 disposed | 59.99 | 208,345.27 | Form 4, filing 0001209191-21-026666 | |
| 2021-04-12 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 998 disposed | 59.10 | 58,981.80 | Form 4, filing 0001209191-21-026666 | |
| 2021-04-12 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 729 disposed | 61.08 | 44,527.32 | Form 4, filing 0001209191-21-026666 | |
| 2021-04-12 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 100 disposed | 61.72 | 6,172.00 | Form 4, filing 0001209191-21-026666 | |
| 2021-03-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 3,557 disposed | 64.72 | 230,209.04 | Form 4, filing 0001209191-21-020480 | |
| 2021-03-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,739 disposed | 63.99 | 111,278.61 | Form 4, filing 0001209191-21-020480 | |
| 2021-03-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 4 disposed | 65.47 | 261.88 | Form 4, filing 0001209191-21-020480 | |
| 2021-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,845 disposed | 65.99 | 121,751.55 | Form 4, filing 0001209191-21-010880 | |
| 2021-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,460 disposed | 63.74 | 93,060.40 | Form 4, filing 0001209191-21-010880 | |
| 2021-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 1,272 disposed | 64.93 | 82,590.96 | Form 4, filing 0001209191-21-010880 | |
| 2021-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 447 disposed | 62.85 | 28,093.95 | Form 4, filing 0001209191-21-010880 | |
| 2021-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 262 disposed | 67.05 | 17,567.10 | Form 4, filing 0001209191-21-010880 | |
| 2021-02-11 |
Keros Therapeutics, Inc. KROS |
S, Open-market sale | 14 disposed | 68.05 | 952.70 | Form 4, filing 0001209191-21-010880 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 47
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Lachey Jennifer, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001808322
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6